Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging
Stopped The delay between diagnosis and initiation of treatment was no longer consistent with standard of care
Conditions
- Macular Degeneration
- Choroidal Neovascularization
Interventions
- DEVICE: Hyperspectral imaging
Sponsor
Center for Eye Research Australia
Collaborators